MiR-212-3p promotes proliferation and migration of trophoblast in fetal growth restriction by targeting placental growth factor

References

• Stanek J. Hypoxic patterns of placental injury: a review. Arch Pathol Lab Med. 2013;137:706–720.
   PubMed Web of Science ®Google Scholar
• Fujimaki A, Watanabe K, Mori T, et al. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta. 2011;32:367–372.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 204: fetal growth restriction. Obstetrics and gynecology, 2019;133:e97–e109.
   PubMed Web of Science ®Google Scholar
• Juan Q, Hongbo Q. Fetal growth restriction: an updated understanding. Chin J Perinat Med. 2015;18:418–420.
   Google Scholar
• Sharma D, Farahbakhsh N, Shastri S, et al. Intrauterine growth restriction - part 2. J Matern Fetal Neonatal Med. 2016;29:4037–4048.
   PubMedGoogle Scholar
• Figueras F, Gratacos E. An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol. 2017;38:48–58.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstetrics and gynecology. 2013;121(5):1122–1133.
   PubMedGoogle Scholar
• Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer. J Pathol. 2011;223:102–115.
   PubMed Web of Science ®Google Scholar
• Li L, Wang S, Li H, et al. microRNA-96 protects pancreatic β-cell function by targeting PAK1 in gestational diabetes mellitus. Biofactors. 2018;44:539–547.
   PubMed Web of Science ®Google Scholar
• Anton L, Olarerin-George AO, Schwartz N, et al. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol. 2013;183:1437–1445.
   PubMed Web of Science ®Google Scholar
• Huang L, Shen Z, Xu Q, et al. Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction. Placenta. 2013;34:624–627.
   PubMed Web of Science ®Google Scholar
• Zou Z, He Z, Cai J, et al. Potential role of microRNA-424 in regulating ERRγ to suppress trophoblast proliferation and invasion in fetal growth restriction. Placenta. 2019;83:57–62.
   PubMed Web of Science ®Google Scholar
• Zhang L, Deng X, Shi X, et al. Silencing H19 regulated proliferation, invasion, and autophagy in the placenta by targeting miR-18a-5p. J Cell Biochem. 2019;120:9006–9015.
   PubMed Web of Science ®Google Scholar
• Gao Y, Guo X, Li Y, et al. The decreased lncRNA ZEB2-AS1 in pre-eclampsia controls the trophoblastic cell line HTR-8/SVneo’s invasive and migratory abilities via the miR-149/PGF axis. J Cell Biochem. 2019;120:17677–17686.
   PubMed Web of Science ®Google Scholar
• Yuan L, Bo L, Shuqiang C, et al. Effect of MiR-133a on adhesion and invasion of trophoblast cell line HTR8-SVneo. J Reprod Med. 2015;24:477–480.
   Google Scholar
• Lili Z, Ying S, Jianghong G, et al. Overexpression of miR-198 inhibits the proliferation, metastasis and invasion of trophoblasts HTR-8/SVneo by targeting and regulating Wnt2B expression. Prog Mod Obstet Gynecol. 2021;2:1–6.
   Google Scholar
• Xie C, Chen B, Wu B, et al. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis. Biomed Pharmacother. 2018;97:1645–1653.
   PubMed Web of Science ®Google Scholar
• Liu H, Li C, Shen C, et al. MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3. J Neurooncol. 2015;122:431–439.
   PubMed Web of Science ®Google Scholar
• Ling D, Zhiqing J, Gu X. Differential expression of miR-212-3p targeting long non-coding RNASCAMP1 in gastric cancer. Huaxia Med J. 2020;33:14–17.
   Google Scholar
• Rodosthenous RS, Burris HH, Sanders AP, et al. Second trimester extracellular microRNAs in maternal blood and fetal growth: an exploratory study. Epigenetics. 2017;12:804–810.
   PubMed Web of Science ®Google Scholar
• Zur RL, Kingdom JC, Parks WT, et al. The placental basis of fetal growth restriction. Obstet Gynecol Clin North Am. 2020;47:81–98.
   PubMed Web of Science ®Google Scholar
• Zou P, Zhu M, Lian C, et al. miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44. Sci Rep. 2019;9:19619.
   PubMed Web of Science ®Google Scholar
• Nardozza LM, Caetano AC, Zamarian AC, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295:1061–1077.
   PubMed Web of Science ®Google Scholar
• Peng F, Tang H, Liu P, et al. Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis. Sci Rep. 2017;7:9022.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu D, Niu H, et al. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res. 2017;36:19.
   PubMed Web of Science ®Google Scholar
• Guerrero-Zotano A, Mayer IA, Arteaga CL. PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment. Cancer Metastasis Rev. 2016;35:515–524.
   PubMed Web of Science ®Google Scholar
• Hamidi A, Song J, Thakur N, et al. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α. Sci Signal. 2017;10:eaal4186.
   PubMed Web of Science ®Google Scholar
• Schneeweiss A, Hess D, Joerger M, et al. Phase 1 dose escalation study of the allosteric AKT inhibitor BAY 1125976 in advanced solid cancer-lack of association between activating AKT mutation and AKT inhibition-derived efficacy. Cancers (Basel). 2019;11:1987.
   PubMed Web of Science ®Google Scholar
• Furmento VA, Blank VC, Madhivanan K, et al. MAPKs and PI3K/Akt pathways are involved in G-CSF-induced migration in a human trophoblast cell line. Placenta. 2015;36: 488-488.
   Web of Science ®Google Scholar
• Pérez-Pérez A, Gambino Y, Maymó J, et al. MAPK and PI3K activities are required for leptin stimulation of protein synthesis in human trophoblastic cells. Biochem Biophys Res Commun. 2010;396:956–960.
   PubMed Web of Science ®Google Scholar
• Tang R, Zhang Z, Han W. CircLRRK1 targets miR-223-3p to inhibit the proliferation, migration and invasion of trophoblast cells by regulating the PI3K/AKT signaling pathway. Placenta. 2021;104:110–118.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhao D. MicroRNA-362-5p promotes the proliferation and inhibits apoptosis of trophoblast cells via targeting glutathione-disulfide reductase. Bioengineered. 2021;12:2410–2419.
   PubMed Web of Science ®Google Scholar
• Goel A, Rana S. Angiogenic factors in preeclampsia: potential for diagnosis and treatment. Curr Opin Nephrol Hypertens. 2013;22:643–650.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA. Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension. 2016;67:1072–1079.
   PubMed Web of Science ®Google Scholar
• Xu B, Shanmugalingam R, Chau K, et al. The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in vitro. J Reprod Immunol. 2017;124:54–61.
   PubMed Web of Science ®Google Scholar
• Kurtoglu E, Avci B, Kokcu A, et al. Serum VEGF and PGF may be significant markers in prediction of severity of preeclampsia. J Matern Fetal Neonatal Med. 2016;29:1987–1992.
   PubMed Web of Science ®Google Scholar
• Knuth A, Liu L, Nielsen H, et al. Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells. Am J Reprod Immunol. 2015;73:330–340.
   PubMed Web of Science ®Google Scholar
• Tao J, Xia LZ, Liang L, et al. MiR-124-3p promotes trophoblast cell HTR-8/SVneo pyroptosis by targeting placental growth factor. Placenta. 2020;101:176–184.
   PubMed Web of Science ®Google Scholar